RxDoctor Payments Data

Howard Farrell, MD

Otolaryngology · Florence, SCNPI 1255323614

Payments from drug & device makers

$649in general payments, 2019–2025

Across 19 payments — averaging $34.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$289
  • Inspire Medical Systems, Inc.$109
  • Integra Lifesciences Corporation$77
  • Medtronic$59
  • Smith+Nephew$53
  • Aerin Medical Inc.$29
  • plus $35 from 2 others

What the payments were for

  • Food & beverage$649100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$649 in reported general payments places this provider in the 30th percentile of 180 otolaryngology providers in South Carolina.

See all otolaryngology providers in South Carolina

Medicare billing

Part B allowed, 2024
$323,664
Medicare patients
1,061
Services billed
4,549

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluticasone Propionate461$10,765
Breo ElliptaFluticasone/Vilanterol22$8,549
Fluocinolone Acetonide Oil89$4,456
Ofloxacin146$4,165
Ipratropium Bromide100$3,817
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth28$3,709
Montelukast Sodium179$2,034
Cefdinir123$1,897
Triamcinolone Acetonide14$938
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip36$843
Pantoprazole Sodium39$803
Omeprazole29$800
Clotrimazole21$778
Levocetirizine Dihydrochloride36$580
Mometasone Furoate16$303

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKBreo Ellipta$23$8,54922 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 180 otolaryngology providers in South Carolina.

Other otolaryngology in Florence

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →